American National Bank of Texas Buys New Shares in The Clorox Company $CLX

American National Bank of Texas bought a new stake in The Clorox Company (NYSE:CLX) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 7,680 shares of the company’s stock, valued at approximately $947,000. Clorox comprises about 0.9% of American National Bank of Texas’ holdings, making the stock its 23rd largest position.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CLX. Total Investment Management Inc. purchased a new stake in shares of Clorox during the 2nd quarter worth about $25,000. American National Bank & Trust increased its stake in Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after buying an additional 89 shares in the last quarter. NewSquare Capital LLC raised its holdings in shares of Clorox by 567.6% during the second quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after acquiring an additional 193 shares during the last quarter. Ransom Advisory Ltd acquired a new position in shares of Clorox during the first quarter valued at approximately $35,000. Finally, Darwin Wealth Management LLC purchased a new position in shares of Clorox in the second quarter valued at approximately $29,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Price Performance

Clorox stock opened at $103.98 on Monday. The company has a current ratio of 0.76, a quick ratio of 0.50 and a debt-to-equity ratio of 18.01. The company has a 50-day moving average price of $109.89 and a 200 day moving average price of $119.14. The Clorox Company has a 12-month low of $98.20 and a 12-month high of $166.35. The stock has a market cap of $12.68 billion, a P/E ratio of 16.32, a PEG ratio of 0.52 and a beta of 0.57.

Clorox (NYSE:CLX) last posted its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.07. The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. Clorox had a net margin of 11.68% and a return on equity of 358.39%. Clorox’s revenue was down 18.9% on a year-over-year basis. During the same period in the previous year, the business posted $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be given a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.8%. The ex-dividend date is Wednesday, January 28th. Clorox’s dividend payout ratio is presently 77.86%.

Analysts Set New Price Targets

CLX has been the subject of several research reports. Citigroup dropped their price target on Clorox from $130.00 to $120.00 and set a “neutral” rating for the company in a research report on Tuesday, November 4th. Rothschild & Co Redburn dropped their target price on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. UBS Group set a $119.00 target price on shares of Clorox and gave the company a “neutral” rating in a research report on Tuesday, November 4th. Bank of America lowered their price target on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Finally, Morgan Stanley dropped their price objective on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 4th. One investment analyst has rated the stock with a Buy rating, thirteen have issued a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, Clorox has a consensus rating of “Reduce” and an average price target of $125.69.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber bought 4,000 shares of Clorox stock in a transaction on Friday, November 21st. The shares were bought at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the transaction, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.63% of the stock is currently owned by company insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.